Literature DB >> 16390355

Thiazide diuretic prescription and electrolyte abnormalities in primary care.

J A Clayton1, S Rodgers, J Blakey, A Avery, I P Hall.   

Abstract

AIMS: Thiazide diuretics have a number of well-documented metabolic adverse effects. The aim of this study was to estimate the frequency of hyponatraemia and hypokalaemia amongst patients taking a thiazide diuretic in primary care.
METHODS: A computerized search of the electronic prescribing and laboratory records of six UK general practices was performed. Of the 32 218 adult patients identified, 3773 had received at least one prescription for a thiazide between the years 1990 and 2002.
RESULTS: Detailed prescribing data were available for 2942 patients of whom 951 (32.3%) had a recorded check of their electrolytes. One hundred and ninety-six (20.6%) had a sodium and/or potassium concentration below the normal range. The sodium distribution had a negative skew (-1.8) and in 130 (13.7%) patients was within the hyponatraemic range. Hypokalaemia was less common, occurring in 79 (8.5%) patients. Hyponatraemia was significantly associated with increased age; the odds ratio for developing hyponatraemia in patients over 70 years was 3.87 compared with those of < or = 70 years. Hypokalaemia was significantly associated with increased thiazide dose.
CONCLUSIONS: Prescription of a thiazide diuretic in primary care is associated with a high frequency of hyponatraemia and hypokalaemia. Thiazides should be prescribed at low dose and the risk of hyponatraemia, especially in the elderly, should be considered and monitored for when prescribing these agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16390355      PMCID: PMC1884982          DOI: 10.1111/j.1365-2125.2005.02531.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

Review 1.  Hyponatremia.

Authors:  H J Adrogué; N E Madias
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

2.  Hyponatremic encephalopathy induced by thiazides.

Authors:  J Al-Salman; R Pursell
Journal:  West J Med       Date:  2001-08

Review 3.  Diuretic complications.

Authors:  A Greenberg
Journal:  Am J Med Sci       Date:  2000-01       Impact factor: 2.378

Review 4.  Systematic review of scope and quality of electronic patient record data in primary care.

Authors:  Krish Thiru; Alan Hassey; Frank Sullivan
Journal:  BMJ       Date:  2003-05-17

Review 5.  Non-potassium-sparing diuretics and risk of sudden cardiac death.

Authors:  D E Grobbee; A W Hoes
Journal:  J Hypertens       Date:  1995-12       Impact factor: 4.844

6.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

7.  Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.

Authors:  L V Franse; M Pahor; M Di Bari; G W Somes; W C Cushman; W B Applegate
Journal:  Hypertension       Date:  2000-05       Impact factor: 10.190

8.  Risk factors for thiazide-induced hyponatraemia.

Authors:  K M Chow; C C Szeto; T Y-H Wong; C B Leung; P K-T Li
Journal:  QJM       Date:  2003-12

Review 9.  The efficacy and safety of diuretics in treating hypertension.

Authors:  E D Freis
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

10.  Diuretic induced hyponatraemia in elderly hypertensive women.

Authors:  Y Sharabi; R Illan; Y Kamari; H Cohen; M Nadler; F H Messerli; E Grossman
Journal:  J Hum Hypertens       Date:  2002-09       Impact factor: 3.012

View more
  30 in total

1.  Dysnatraemias in the emergency room: Undetected, untreated, unknown?

Authors:  Spyridon Arampatzis; Aristomenis Exadaktylos; Daniela Buhl; Heinz Zimmermann; Gregor Lindner
Journal:  Wien Klin Wochenschr       Date:  2011-12-21       Impact factor: 1.704

2.  Chronic kidney disease: the effect of CKD therapies on serum potassium levels.

Authors:  Jeffrey C Fink
Journal:  Nat Rev Nephrol       Date:  2010-11       Impact factor: 28.314

3.  Oversight: a retrospective study of biochemical monitoring in patients beginning antihypertensive drug treatment in primary care.

Authors:  Jamie J Coleman; Sarah E McDowell; Stephen J W Evans; Paramjit S Gill; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

4.  Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.

Authors:  Jörg Indermitte; Sabine Burkolter; Jürgen Drewe; Stephan Krähenbühl; Kurt E Hersberger
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Biochemical monitoring of patients treated with antihypertensive therapy for adverse drug reactions: a systematic review.

Authors:  Sarah E McDowell; Robin E Ferner
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606

Review 6.  Sensing of tubular flow and renal electrolyte transport.

Authors:  Eric H J Verschuren; Charlotte Castenmiller; Dorien J M Peters; Francisco J Arjona; René J M Bindels; Joost G J Hoenderop
Journal:  Nat Rev Nephrol       Date:  2020-03-03       Impact factor: 28.314

Review 7.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

8.  Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.

Authors:  Volker Burst; Franziska Grundmann; Torsten Kubacki; Arthur Greenberg; Ingrid Becker; Despina Rudolf; Joseph Verbalis
Journal:  Am J Nephrol       Date:  2017-04-19       Impact factor: 3.754

9.  Hyponatremia independent of osteoporosis is associated with fracture occurrence.

Authors:  Sinead Kinsella; Sarah Moran; Miriam O Sullivan; Michael G M Molloy; Joseph A Eustace
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

10.  Costs of eprosartan versus diuretics for treatment of hypertension in a geriatric population: an observational, open-label, multicentre study.

Authors:  Joaquin A Alvarez Gregori; Juan F Macías Nuñez; Alfonso Domínguez-Gil
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.